NR3C2 and dementia: This study therefore aimed to investigate the risk of dementia in individuals with PA, grouped by adrenalectomy (ADX) or mineralocorticoid receptor antagonist (MRA) treatment, compared to age- and sex-matched EH controls using a nationwide cohort.